Covered recipient · General Payments record
KIA JEAN BROWN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,711.59
- Reported across 135 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $511.91 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $118.98 | 1 |
| Acerta Pharma LLC | $111.05 | 1 |
| Corium, Inc. | $76.56 | 5 |
| ABBVIE INC. | $65.27 | 3 |
| Regeneron Healthcare Solutions, Inc. | $34.48 | 1 |
| Lilly USA, LLC | $24.78 | 1 |
| PFIZER INC. | $23.94 | 1 |
| GlaxoSmithKline, LLC. | $21.49 | 1 |
| Novo Nordisk AS | $18.38 | 1 |
| Cranial Technologies, Inc | $16.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.14 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106834070 | CMS |
| ABBVIE INC. | $15.87 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106834072 | CMS |
| ABBVIE INC. | $24.26 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106834074 | CMS |
| AstraZeneca Pharmaceuticals LP | $111.05 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105551208 | CMS |
| Corium, LLC | $18.89 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100101512 | CMS |
| Corium, LLC | $13.72 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100115816 | CMS |
| Corium, LLC | $14.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100114412 | CMS |
| Corium, LLC | $14.91 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100113040 | CMS |
| Corium, LLC | $14.65 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100163637 | CMS |
| Cranial Technologies, Inc | $16.98 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082246020 | CMS |
| GENZYME CORPORATION | $118.98 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139608658 | CMS |
| GlaxoSmithKline, LLC. | $21.49 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116164835 | CMS |
| Lilly USA, LLC | $24.78 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135779190 | CMS |
| Novo Nordisk Inc | $18.38 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588089 | CMS |
| PFIZER INC. | $23.94 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131458726 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.48 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114277691 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.